The launch of the 750mcg teriparatide formulation in Australia has seen controlled distribution to date. Primarily directed for patients with severe skeletal fragility who have not responded to other therapies https://750-mcg-teriparatide-inj601917.blognody.com/52041056/750mcg-teriparatide-injection-australia-availability